406232-79-9

Basic information

• Product Name: 5-Bromo-2-chloro(trifluoromethoxy)benzene
• Synonyms: 5-Bromo-2-chloro(trifluoromethoxy)benzene;4-Bromo-1-chloro-2-(trifluoromethoxy)benzene;5-Bromo-2-chloro-1-trifluoromethoxybenzene
• CAS NO: 406232-79-9
• Molecular Formula: C7H3BrClF3O
• Molecular Weight: 275.4503296
• Mol File: 406232-79-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 194.278 °C at 760 mmHg
• Flash Point: 71.297 °C
• Appearance: /
• Density: 1.744 g/cm³
• Vapor Pressure: 0.622mmHg at 25°C
• Refractive Index: 1.494
• CAS DataBase Reference: 5-Bromo-2-chloro(trifluoromethoxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-chloro(trifluoromethoxy)benzene(406232-79-9)
• EPA Substance Registry System: 5-Bromo-2-chloro(trifluoromethoxy)benzene(406232-79-9)

Safety Data

• Hazardous Substances Data: 406232-79-9(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-chloro(trifluoromethoxy)benzene is a chemical compound with the molecular formula C7H3BrClF3O. It is commonly used in organic synthesis and pharmaceutical research due to its unique chemical properties. 5-Bromo-2-chloro(trifluoromethoxy)benzene is a halogenated benzene derivative, containing bromine, chlorine, and trifluoromethoxy groups attached to the benzene ring. It is known for its high chemical reactivity and is often used as a building block in the synthesis of various organic compounds. 5-Bromo-2-chloro(trifluoromethoxy)benzene is a colorless liquid at room temperature and is often handled with care due to its potential health hazards. It is also important to note that this compound should only be handled by trained professionals in a laboratory setting.

InChI:InChI=1/C7H3BrClF3O/c8-4-1-2-5(9)6(3-4)13-7(10,11)12/h1-3H

Upstream product

• 1535-75-7 2-trifluoromethoxy aniline 
• 175278-09-8 4-bromo-2-(trifluoromethoxy)aniline 
• 7447-39-4 copper(II) chloride 

Downstream Products

• 902757-07-7 4-chloro-3-(trifluoromethoxy)phenylboronic acid 

Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION

There is provided compounds of formula (I), Wherein X1 , R1 , R2 , R3, R4, R5 and R6 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.

N-acylsulfonamide apoptosis promoters

N-Benzoyl arylsulfonamides having the formula are BCL-Xl inhibitors and are useful for promoting apoptosis. Also disclosed are BCL-Xl inhibiting compositions and methods of promoting apoptosis in a mammal.